Letter of Medical Necessity for GLP-1: Template and Guide
Free template and complete guide for obtaining a letter of medical necessity for GLP-1 medications. Learn what information to include, how to work with your provider, and how this letter strengthens insurance appeals.
More on Insurance & Coverage
What Is a Letter of Medical Necessity?
A letter of medical necessity (LMN) is a formal clinical document written by your healthcare provider that explains why a specific GLP-1 medication is medically required for your condition. Unlike a standard prescription, which simply states what medication to dispense, an LMN provides the clinical reasoning, documentation of failed alternatives, and evidence-based justification that insurance companies need to approve coverage.
Insurance companies use LMNs to distinguish between treatments that are medically necessary (and therefore covered) and those they consider optional, experimental, or cosmetic. For GLP-1 weight management medications, a strong LMN is often the difference between approval and denial.
Provider Letter Template
[Provider Name, Credentials] [Practice Name] [Address] [Phone/Fax] [Date] [Insurance Company] Medical Review Department [Address] RE: Letter of Medical Necessity Patient: [Patient Name] DOB: [Date of Birth] Member ID: [Number] Medication: [Drug Name, Dose] To Whom It May Concern, I am writing to establish the medical necessity of [medication name] for my patient, [patient name], for the treatment of chronic obesity with associated comorbidities. CLINICAL PRESENTATION: [Patient name] presents with a BMI of [XX] kg/m2 (height: [X], weight: [X] lbs). The patient has been diagnosed with the following obesity-related conditions: - [ICD-10 code] - [Diagnosis, e.g., E66.01 - Morbid obesity] - [ICD-10 code] - [Comorbidity 1] - [ICD-10 code] - [Comorbidity 2] - [Additional conditions] FAILED PRIOR INTERVENTIONS: The patient has attempted the following weight management interventions without achieving sustained, clinically significant weight loss: - [Structured diet program, dates, outcome] - [Exercise program, dates, outcome] - [Prior medication if any, dates, outcome] - [Behavioral counseling, dates, outcome] CLINICAL RATIONALE: [Medication name] is FDA-approved for chronic weight management in adults with BMI >=30 or BMI >=27 with at least one weight-related comorbidity. The following clinical evidence supports its use: 1. [Relevant clinical trial] demonstrated [X]% body weight reduction 2. The SELECT cardiovascular outcomes trial showed 20% reduction in MACE 3. [Additional relevant evidence for this patient's comorbidities] Given the severity of the patient's obesity and associated comorbidities, the failure of less intensive interventions, and the strong clinical evidence supporting [medication name], I believe this medication is medically necessary for this patient. Less intensive alternatives have been tried and failed as documented above. Without pharmacological intervention, this patient faces progressive worsening of [specific conditions] and increased risk of [specific outcomes]. I am available to discuss this case at [phone number]. Sincerely, [Provider Name, Credentials] [NPI Number] [DEA Number if required]
Key Elements That Strengthen the Letter
- ICD-10 codes: Using specific diagnosis codes demonstrates clinical documentation and makes the letter easier for insurance reviewers to process.
- Specific lab values: Include A1C, fasting glucose, lipid panel results, and other relevant data with dates. Numbers are more compelling than general statements.
- Quantified failed attempts: "Patient participated in a 12-week structured Weight Watchers program from January-March 2025, losing 8 lbs with complete regain by June 2025" is stronger than "patient has tried dieting."
- Clinical trial citations: Reference specific trials by name with key statistics. This demonstrates evidence-based prescribing.
- Cost-effectiveness argument: If applicable, note that the cost of the medication is less than the projected cost of treating untreated complications (diabetes medications, cardiovascular events, joint replacements).
- Professional guidelines: Cite AMA, AHA, or Endocrine Society guidelines recognizing obesity as a chronic disease requiring medical treatment. Learn about the clinical basis for GLP-1 therapy.
Medical Disclaimer: This template is provided for educational purposes. Individual letters should be customized by your healthcare provider to reflect your specific clinical situation. This article does not constitute legal or medical advice.
Frequently Asked Questions
Who writes a letter of medical necessity?
The letter is written by your prescribing healthcare provider (physician, NP, or PA). You can help by providing a template and gathering your medical documentation, but the letter must come from a licensed provider with clinical authority. Some providers have standard templates they use; others appreciate receiving a framework to work from.
What makes a letter of medical necessity effective?
Effective letters include specific clinical data (exact BMI, lab values, comorbidity diagnoses with ICD-10 codes), documentation of failed alternatives, citations from clinical trials, explanation of why less expensive alternatives are inadequate, and a clear statement that the requested medication is medically necessary rather than optional or cosmetic.
Can I write the letter and have my doctor sign it?
You can draft the letter and provide it to your provider as a starting point, but they should review, modify, and personalize it with your specific clinical details before signing. A generic letter that clearly was not written by the provider is less effective than a personalized clinical narrative. Many providers appreciate having a template that saves them time.
How is this different from an appeal letter?
A letter of medical necessity is a clinical document from your provider supporting why the medication is medically required. An appeal letter is from you (the patient) to the insurance company requesting reversal of a denial. The letter of medical necessity is typically enclosed as supporting documentation with your appeal letter. Both are needed for a strong appeal.
Do I need a new letter for each refill?
Generally no. The initial letter of medical necessity covers ongoing treatment. However, if your insurance requires annual re-authorization or if you switch medications, a new or updated letter may be needed. Keep copies of all letters and correspondence for your records.
Our Providers Write Medical Necessity Letters
We handle insurance documentation as part of your treatment plan.
Get Started TodaySources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).